Valneva SE (NASDAQ:VALN) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET
Company Participants
Joshua Drumm - VP, IR
Thomas Lingelbach - Chairman, President & CEO
Peter Buhler - CFO
Conference Call Participants
Kevin Strang - Jefferies
Edward White - H.C. Wainwright & Co
Boran Wang - Guggenheim Securities
Simon Scholes - First Berlin
Rajan Sharma - Goldman Sachs Group
Samir Devani - Rx Securities Limited
Max Herrmann - Stifel, Nicolaus & Company
Operator
Good day and thank you for standing by. Welcome to the Valneva present its Q1 2023 Financial Results Conference Call. [Operator Instructions].
I would now like to hand the conference over to your host today, Joshua Drumm, Vice President of Global Investor Relations. Please go ahead.
Joshua Drumm
Thank you, Sharon. Hello and thank you for joining us to discuss Valneva's first quarter 2023 results and corporate update. It's my pleasure to welcome you today. In addition to our press release and analyst presentation, you can find our consolidated financial results for the quarter, which were published earlier today, available within the Financial Report section of our investor website. I'm joined by Valneva's CEO, Thomas Lingelbach and CFO, Peter Buhler, who will provide an overview and update on our business, as well as our key financial results for the quarter. There will be an analyst Q&A session at the conclusion of the prepared remarks.
Before we begin, I'd like to remind listeners that during the presentation, we will be making forward-looking statements, which are subject to certain risks and uncertainties that could cause the actual results to differ materially from those expressed or implied by these forward-looking statements. You can find information about these risk and uncertainties in our periodic filings with the Securities and Exchange Commission and with the French market authority, which are listed on our company website. Please note that today's presentation includes information provided as of today, May the 4th, 2023 and Valneva undertakes no obligation to revise or update forward-looking statements except as required by applicable securities laws.
With that, it's my pleasure to introduce Thomas to begin today's presentation.
Thomas Lingelbach
Thank you so much, Josh and good day to everyone. Great pleasure to present couple of updates with regards to our quarter one and later Peter to present the financial report. Yeah, we have a very good momentum right now, driven on the one hand side by our strong sales performance, but also increasing clarity on our key catalyst. Our product sales in the first quarter nearly doubled year-over-year, was primarily driven by our proprietary product IXIARO and DUKORAL, both of which more than quadrupled from quarter one 2022.